Peregrine Capital Management’s Lifestance Health LFST Stock Holding History

Peregrine Capital Management’s Portfolio LFST Stock Details LFST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$7.65M	Buy	+635,630	New	+$7.5M	0.26%	121

Other funds holding LFST

Summit Partners Boston, Massachusetts $491M AUM 11.09% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Peregrine Capital Management's LFST Position: Q3 2026 in Review

Peregrine Capital Management opened a new position in Lifestance Health (LFST) in Q3 2026: 635,630 shares worth $7.65M. The stake represents 0.26% of the portfolio and ranks #121 among its holdings.

147 funds tracked by Wall St. Rank hold LFST as of Q3 2026.

Peregrine Capital Management held 635,630 shares of Lifestance Health worth $7.65M as of Q3 2026.
Lifestance Health was a new Peregrine Capital Management position in Q3 2026.
Lifestance Health made up 0.26% of Peregrine Capital Management's portfolio in Q3 2026, its #121 holding.
147 funds tracked by Wall St. Rank held Lifestance Health as of Q3 2026.

Based on Peregrine Capital Management's 13F filing for Q3 2026, filed 9 Nov 2026.